SIGNPATH PHARMA, INC.
CIK 0001455694
Revenue (TTM)
—
FY Mar 2023
Net Income (TTM)
−$2M
+40.5% YoY
FY Mar 2023
EPS Diluted (TTM)
—
FY Mar 2023
Gross Margin
—
FY Mar 2023
Operating Margin
—
FY Mar 2023
Net Margin
—
FY Mar 2023
Free Cash Flow (TTM)
−$1.58M
FY Mar 2023
Cash
$1.34M
FY Mar 2023
Total Debt
—
FY Mar 2023
Shares Outstanding
12.84M sh
FY Mar 2023
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.